| Schedule of Condensed Balance Sheets |
The following presents condensed parent
company only financial information of Triller Group Inc.
| |
As of December 31, | |
| | |
2024 | | |
2023 | |
| ASSETS | |
| | |
| |
| Current assets: | |
| | | |
| | |
| Cash and cash equivalents | |
$ | 3 | | |
$ | 130 | |
| Amounts due from stockholder | |
| — | | |
| 133 | |
| Amounts due from subsidiaries | |
| 66,088 | | |
| 909 | |
| Promissory notes receivable, related party | |
| 33,949 | | |
| — | |
| Prepayments | |
| 155 | | |
| 453 | |
| Total current assets | |
| 100,195 | | |
| 1,625 | |
| | |
| | | |
| | |
| Non-current assets: | |
| | | |
| | |
| Investments in subsidiaries | |
| 785,733 | | |
| — | |
| Total non-current assets | |
| 785,733 | | |
| — | |
| | |
| | | |
| | |
| TOTAL ASSETS | |
$ | 885,928 | | |
$ | 1,625 | |
| | |
| | | |
| | |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |
| | | |
| | |
| Current liabilities: | |
| | | |
| | |
| Other payable and accrued liabilities | |
$ | 8,930 | | |
$ | 3,739 | |
| Borrowings | |
| 32,552 | | |
| | |
| Borrowings, related party | |
| 18,443 | | |
| — | |
| Warrant liabilities | |
| 977 | | |
| — | |
| Total current liabilities | |
| 60,902 | | |
| 3,739 | |
| | |
| | | |
| | |
| TOTAL LIABILITIES | |
| 60,902 | | |
| 3,739 | |
| | |
| | | |
| | |
| Commitments and contingencies (Note 25) | |
| | | |
| | |
| | |
| | | |
| | |
| Stockholders’ equity (deficit)*: | |
| | | |
| | |
| Preferred stock, $0.001 par value, 100,000,000 shares authorized | |
| | | |
| | |
| Series A-1 preferred stock, $0.001 par value, 50,000,000 and nil shares authorized, 11,801,804 shares and nil issued and outstanding as of December 31, 2024 and 2023, respectively | |
| 12 | | |
| — | |
| Series B preferred stock, $0.001 par value, 50,000,000 and nil shares authorized, 30,851 shares and nil issued and outstanding as of December 31, 2024 and 2023, respectively | |
| — | ** | |
| — | |
| Common stock, $0.001 par value; 150,000,000,000 and 484,125,000 shares authorized, 138,143,817 and 33,240,991 shares issued and outstanding as of December 31, 2024 and 2023, respectively# | |
| 138 | | |
| 69 | |
| Series A-1 preferred stock to be issued | |
| 12 | | |
| — | |
| Common stock to be issued# | |
| 15 | | |
| 5 | |
| Common stock held in escrow | |
| 24 | | |
| — | |
| Additional paid-in capital | |
| 909,806 | | |
| 19,507 | |
| Accumulated deficit | |
| (84,981 | ) | |
| (21,695 | ) |
| Total stockholders’ equity (deficit) | |
| 825,026 | | |
| (2,114 | ) |
| | |
| | | |
| | |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | |
$ | 885,928 | | |
$ | 1,625 | |
| | # | Giving retroactive effect to the forward stock split and reverse stock split (see Note 19) |
| | * | Giving retroactive effect to the AGBA Domestication completed on October 15, 2024 (see Note 1) |
| | ** | Less than $1,000 |
|
| Schedule of Condensed Statements of Operations |
| |
For the years ended
December 31, | |
| | |
2024 | | |
2023 | |
| Operating cost and expenses: | |
| | |
| |
| Stock-based compensation expense | |
$ | (51,671 | ) | |
$ | (9,933 | ) |
| Other general and administrative expenses | |
| (11,066 | ) | |
| (3,764 | ) |
| Total operating cost and expenses | |
| (62,737 | ) | |
| (13,697 | ) |
| | |
| | | |
| | |
| Loss from operations | |
| (62,737 | ) | |
| (13,697 | ) |
| | |
| | | |
| | |
| Other income (expense): | |
| | | |
| | |
| Interest income | |
| 765 | | |
| — | |
| Interest expense | |
| (4,546 | ) | |
| — | |
| Interest expense, related party | |
| (231 | ) | |
| — | |
| Change in fair value of warrant liabilities | |
| 3,463 | | |
| 4 | |
| Change in fair value of forward share purchase liability | |
| — | | |
| (82 | ) |
| Loss on settlement of forward share purchase agreement | |
| — | | |
| (379 | ) |
| Sundry income | |
| — | | |
| 344 | |
| Total other income (expense), net | |
| (549 | ) | |
| (113 | ) |
| | |
| | | |
| | |
| Loss before income taxes | |
| (63,286 | ) | |
| (13,810 | ) |
| | |
| | | |
| | |
| Income tax expense | |
| — | | |
| — | |
| | |
| | | |
| | |
| NET LOSS | |
$ | (63,286 | ) | |
$ | (13,810 | ) |
|
| Schedule of Condensed Statement of Cash Flows |
| |
Years ended December 31, | |
| | |
2024 | | |
2023 | |
| Cash flows from operating activities: | |
| | | |
| | |
| Net loss | |
$ | (63,286 | ) | |
$ | (13,810 | ) |
| Adjustments to reconcile net loss to net cash used in operating activities | |
| | | |
| | |
| Stock-based compensation expense | |
| 51,671 | | |
| 9,933 | |
| Change in fair value of warrant liabilities | |
| (3,463 | ) | |
| (4 | ) |
| Change in fair value of forward share purchase liability | |
| — | | |
| 82 | |
| Loss on settlement of forward share purchase agreement | |
| — | | |
| 379 | |
| Interest income from promissory note receivable, related party | |
| (765 | ) | |
| — | |
| Interest expenses on borrowings | |
| 4,777 | | |
| — | |
| | |
| | | |
| | |
| Change in operating assets and liabilities: | |
| | | |
| | |
| Prepayments | |
| 658 | | |
| (17 | ) |
| Other payables and accrued liabilities | |
| 6,399 | | |
| 1,161 | |
| Net cash used in operating activities | |
| (4,009 | ) | |
| (2,276 | ) |
| | |
| | | |
| | |
| Cash flows from investing activities: | |
| | | |
| | |
| Issuance of promissory notes receivable, related party | |
| (15,465 | ) | |
| — | |
| Net cash used in investing activities | |
| (15,465 | ) | |
| — | |
| | |
| | | |
| | |
| Cash flows from financing activities: | |
| | | |
| | |
| Advances to related companies | |
| (4,003 | ) | |
| (934 | ) |
| Proceeds from convertible promissory note payables | |
| 23,350 | | |
| — | |
| Settlement of forward share purchase agreement | |
| — | | |
| (13,953 | ) |
| Proceeds from private placement | |
| — | | |
| 1,850 | |
| Net cash provided by (used in) financing activities | |
| 19,347 | | |
| (13,037 | ) |
| | |
| | | |
| | |
| Net change in cash and cash equivalents | |
| (127 | ) | |
| (15,313 | ) |
| | |
| | | |
| | |
| BEGINNING OF YEAR | |
| 130 | | |
| 15,443 | |
| | |
| | | |
| | |
| END OF YEAR | |
$ | 3 | | |
$ | 130 | |
|